Pharmacokinetics Tutoring

Slides:



Advertisements
Similar presentations
Instant Clinical Pharmacology E.J. Begg
Advertisements

First, zero, pseudo-zero order elimination Clearance
PHARMACOKINETIC.
Pharmacokinetics Questions
Nonlinear pharmacokinetics
1 Intravenous Infusion Equations Some drugs are administered using a continuous intravenous infusion, and if the infusion is discontinued the serum concentration/time.
Multiple IV Dosing Pharmacokinetic Research, Bioequivalence Studies,
Index of Simulations 1-Compartment, IV bolus 1-Compartment, IV infusion: Steady- State1-Compartment, IV infusion: Steady- State 1-Compartment, IV infusion:
Laplace transformation
Practical Pharmacokinetics
Practical Pharmacokinetics September 11, 2007 Frank F. Vincenzi.
Dose Adjustment in Renal and Hepatic Disease
Dosing Regimen Design Infusion regimen.
Gokaraju Rangaraju College of Pharmacy
INTRAVENOUS INFUSION.
The General Concepts of Pharmacokinetics and Pharmacodynamics Hartmut Derendorf, PhD University of Florida.
PLASMA HALF LIFE ( t 1/2 ).  Minimum Effective Concentration (MEC): The plasma drug concentration below which a patient’s response is too small for clinical.
Intravenous Infusion Previous rates of administration were instantaneous IV bolus and first order absorption. As a rate (mg/hr) a first order rate constantly.
The General Concepts of Pharmacokinetics and Pharmacodynamics
Multiple dosing: intravenous bolus administration
1 Single-dose kinetics Plasma [Drug] curve Upon administration [drug] plasma reaches a max Then begins to decline as the Drug is eliminated Cp max = max.
CLINICAL PHARMACOKINETICS OF LIDOCAINE
PHARMACOKINETICS INTRODUCTION
Continuous intravenous infusion (one-compartment model)
BIOPHARMACEUTICS.
Prof. Dr. Henny Lucida, Apt
Design of Sustained Release Dosage Forms
Clinical Pharmacokinetic Equations and Calculations
Lecture 2 Clearance, maintenance dose and AUC
The General Concepts of Pharmacokinetics and Pharmacodynamics
Pharmacokinetics 2 General Pharmacology M212
Objectives Compartment Modeling of Drugs Models describing drug concentration-time profiles Multi-compartment Models.
Learning objectives To know what data is available from pharmacokinetic studies in man and how to handle it To know how to calculate the basic pharmacokinetic.
Pharmacokinetics: Digoxin Allie Punke
Pharmacokinetic Questions
Pharmacokinetics 3rd Lecture
Compartmental Models and Volume of Distribution
Allie punke Pharmacokinetics tutoring Fall 2016
Anticonvulsants: Phenytoin
Allie punke Pharmacokinetics tutoring Fall 2016
The aminoglycoside antibiotics
Chapter 7 COMPARTMENT MODELS
Allie punke Pharmacokinetics tutoring Fall 2016
Pharmacokinetic Modeling (describing what happens)
Pharmacokinetics.
PHARMACOKINETICS Allie punke
Controls and Functions
Pharmacokinetics.
Pharmacokinetics Tutoring
Dosing Regimen Concepts: 2-C, MM, Individualization principles
Controlled drug release
Pharmacokinetics.
Quantitative Pharmacokinetics
Pharmacokinetics: Theophylline
Pharmacokinetics: immunosuppressive drugs
PHARMACOKINETICS Allie punke
School of Pharmacy, University of Nizwa
Clinical Pharmacokinetics
Allie Punke Pharmacokinetics Allie Punke
Therapeutic Drug Monitoring
Selected Bioavailability and Pharmacokinetic Calculations
1 Concentration-time curve
School of Pharmacy, University of Nizwa
Therapeutic Drug Monitoring chapter 1 part 1
Multiple ORAL Dosing Objectives
Q1: Drug A is a small and hydrophilic compound that distributes to extracellular fluids only. It has a volume of distribution of 5.6 L in a healthy 70-kg.
REFERENCE: APPLIED CLINICAL Slideshow by: lecturer HADEEL DELMAN
A loading dose decreases the time to achieve the target concentration.
A change in either volume of distribution or clearance has differing effects on the concentration-time profile. A change in either volume of distribution.
Presentation transcript:

Pharmacokinetics Tutoring

Constant rate infusion Therapeutic Regimen 1 Constant rate infusion

Constant rate infusion A drug is administered via continuous infusion at a rate of 60mg/h, resulting in a steady state plasma concentration of 5mcg/mL. IF the plasma concentration is intended to be doubled to 10 mcg/mL, the infusion rate must be: A. left he same B. Increaed by 30mg/h C. Increased by 60 mg/h D. increased by 120mg/h E. decreased by 30 mg/h

Constant rate infusion

Loading and maintenance dose You and your team determine that your patient has an increase in Volume. Which of the following needs to be done in his regimen? A. Increase in LD and MD B. Increase LD; same MD C. Same LD; increase MD D. Both remain the same. B

Loading and maintenance dose RW is a 30 yo WM who is beginning therapy on aminophylline. The team has decided to give him a LD. The Css the team would like to achieve is 10 mg/L of theophylline. The population values are Vd=40L and CL=3.3L/hr. What is the LD and MD of aminophyllne? LD A. 400mg B. 450mg C. 500mg D. 550mg MD A. 29mg/h B. 50mg/h C. 36mg/h D. 40mg/h

Constant rate infusion ZW received a 1 gram dose of ceftriaxone over a 30 minute infusion. What is the patients clearance if you measure the concentration of 10.2mg/L at 15 minutes. Assume k=0.067hr-1 A. 2.8L/h B. 3.3L/h C. 3.9L/h D. 4.5L/h

Constant rate infusion TB is a 76 yo WF who is experiencing toxicity from drug X on a current regimen of 90mg/h. After 6 days of therapy, a steady state blood level is drawn and found to be 23 mg/L. TR is 5-15 mg/L. If this infusion is stopped, how long until the patient would be at 10mg/L? Assume Vd of 50L. A. 10.6 h B. 13.9 h C. 15 h D. 17.7 h

Constant rate infusion What should the new infusion rate be? 10mg/h 20mg/h 30mg/h 40mg/h

Constant rate infusion How long until the patient will be at new Css? 33 hours 44 hours 55 hours 66 hours

Time to css The time to reach Css is determined by: A. Rate of infusion (R0) B. Elimination rate constant (K) C. Absorption rate constant (Ka) D. The maximum concentration (Cmax)

Continuous IV infusion CL=4.6L/h, V=35L, k=0.143 Therapeutic Range= 10-15 (Assume we are targeting 13mg/L) LD=___________ (Assume it is given over 45 minutes) MD=___________ Calculate the concentrations at the following time points (Assume both the LD and MD infusions are started at the same time): 20 minutes

Continuous iv infusion 1 hour, 10 minutes 24 hours

multicompartment What is an acceptable way to overcome the issue with giving a loading dose of a drug exhibiting multi-compartment characteristics? A. Give as a continuous infusion B. Give a LD based on the Volume of the central compartment C. Give a LD based on post-equilibrium Vd D. Multiple small bolus injections.

multicompartment When is the best time to obtain a drug sample if a patient is given an IV drug that has multicompartment characteristics? A. Right after you give the IV drug B. There’s no good time to obtain the drug sample C. Wait until distribution is over

Questions? Enjoy your weekend!